Practitioner Articles
-
Guna Low-Dose Cytokine Support in Autoimmune Conditions
Guna low-dose cytokine support in autoimmune states uses orally administered cytokines and signalling molecules in homeopathic low dilution (typically 4CH) to gently nudge immune signalling toward balance, paired with PNEI...
-
Guna Low-Dose Interleukin Protocol for Allergic Conditions
In allergic conditions the low-dose cytokine approach uses orally administered interleukin preparations at physiological, sequentially activated dilutions to support immune regulation rather than to suppress it. The aim is to...
-
Designing a Guna Method Protocol: Drainage, PNEI Rebalance and Symptom
The Guna Method structures a case in three coordinated layers: drainage of the extracellular matrix and emunctories, PNEI rebalancing of the psychoneuroendocrine-immune network, and targeted symptom support. Designing a protocol...
-
A PNEI Protocol for Sleep and Circadian Regulation
A PNEI approach to sleep treats disturbed sleep as a signalling problem across the psychoneuroendocrine-immune network — stress-axis overactivation, blunted wind-down and circadian drift — rather than as an isolated...
-
Low-Dose Neurotrophins in Practice (BDNF and the Neuroendocrine Axis)
Low-dose neurotrophin therapy uses homeopathically diluted signalling molecules such as BDNF (4CH) to gently support neuroplasticity and neuroendocrine communication. In practice, Guna BDNF 4CH is paired with a neuroendocrine-mood remedy...
-
The PNEI Approach to Stress and HPA-Axis Dysregulation
A PNEI (psycho-neuro-endocrine-immune) approach to stress and HPA-axis dysregulation uses low-dose, physiological-regulating remedies to support communication across the stress network rather than to suppress a single symptom. Sepia Compositum (Guna...
-
Practitioner Protocol for Menopausal Support
The antihomotoxic approach to menopausal support addresses the transition on three levels: the neuroendocrine terrain, the mood and PNEI dimension, and the characteristic vasomotor and constitutional symptoms. The aim is...